Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

BACKGROUND/AIM: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has become the standard approach for patients with relapsed/refractory Hodgkin’s lymphoma (HL) or non-Hodgkin’s lymphoma (NHL). In this study, we report the outcome of the mitoxantrone-melphalan conditioni...

Descripción completa

Detalles Bibliográficos
Autores principales: OKAY, Müfide, BÜYÜKAŞIK, Yahya, DEMİROĞLU, Haluk, MALKAN, Ümit Yavuz, ÇİFTÇİLER, Rafiye, ALADAĞ, Elifcan, AKSU, Salih, HAZNEDAROĞLU, İbrahim Celalettin, SAYINALP, Nilgün, ÖZCEBE, Osman İlhami, GÖKER, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018231/
https://www.ncbi.nlm.nih.gov/pubmed/31293116
http://dx.doi.org/10.3906/sag-1809-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018231/
https://www.ncbi.nlm.nih.gov/pubmed/31293116
http://dx.doi.org/10.3906/sag-1809-36

Ejemplares similares